Jazz Pharmaceuticals Reports Results For Zepzelca And Atezolizumab Combo In First-Line Maintenance For Small Cell Lung Cancer

Benzinga · 10/15 11:35

Jazz plans to submit supplemental New Drug Application in first half of 2025 for this combination therapy as a first-line maintenance treatment for ES-SCLC